Add Yahoo as a preferred source to see more of our stories on Google. Analysis shows that incidence rates for both males and females showed little or no decrease from 2019 onwards - AFP via Getty ...
SAN DIEGO — The University of California, San Diego has paused at least five clinical trials designed to cure or control HIV ...
Long-Acting Injectable ART Holds Up Through 48 Weeks in Young People Living With HIV in South Africa
Young people living with HIV in South Africa achieve high viral suppression rates on long-acting injectable antiretroviral therapy, and all who finished the study chose to continue treatment.
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...
Patients with HIV who had frequent outpatient psychiatric visits and poor viral control faced a significantly higher likelihood for hospital admission.
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...
Scientific advances and effective treatment regimens have transformed HIV from the “near-certain death sentence” it represented in the 1980s to a chronic disease. Today, people with HIV (PWH) have a ...
Share on Pinterest Lenacapavir is a twice-yearly injection to prevent HIV that could improve adherence rates compared to other PrEP medications. d3sign/Getty Images The WHO issued a global ...
Untreated human immunodeficiency virus (HIV) infection markedly increases the risk of tuberculosis, which remains the most common cause of hospitalization and death globally among people with HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results